UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiple Sclerosis-Like Symptoms in Mice Are Driven by Latent γHerpesvirus-68 Infected B Cells

Frontiers in immunology, 2020-11, Vol.11, p.584297-584297

2020

Volltextzugriff (PDF)

Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis

Scientific reports, 2015-09, Vol.5 (1), p.13995-13995, Article 13995

2015

Volltextzugriff (PDF)

Influence of Type I Interferons in Gammaherpesvirus-68 and Its Influence on EAE Enhancement

Frontiers in immunology, 2022-07, Vol.13, p.858583-858583

2022

Volltextzugriff (PDF)

The Role of Latently Infected B Cells in CNS Autoimmunity

Frontiers in immunology, 2015-10, Vol.6, p.544-544

2015

Volltextzugriff (PDF)

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study

Scientific reports, 2024-04, Vol.14 (1), p.8926-8926, Article 8926

2024

Volltextzugriff (PDF)

Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults

BMC infectious diseases, 2024-01, Vol.24 (1), p.91-91, Article 91

2024

Volltextzugriff (PDF)

Spatial kinetics and immune control of murine cytomegalovirus infection in the salivary glands

PLoS computational biology, 2024-08, Vol.20 (8), p.e1011940

2024

Volltextzugriff (PDF)

Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada

Scientific reports, 2023-10, Vol.13 (1), p.17930-17930, Article 17930

2023

Volltextzugriff (PDF)

Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks

Frontiers in immunology, 2022-01, Vol.12, p.775420-775420

2022

Volltextzugriff (PDF)

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex

Science (American Association for the Advancement of Science), 2022-02, Vol.375 (6582), p.760-764

2022

Volltextzugriff (PDF)

Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study

Viruses, 2022-10, Vol.14 (11), p.2416

2022

Volltextzugriff (PDF)

Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response

Microbiology spectrum, 2022-04, Vol.10 (2), p.e0140521-e0140521

2022

Volltextzugriff (PDF)

Erratum for Nikiforuk et al., “Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response”

Microbiology spectrum, 2022-10, Vol.10 (5), p.e0337622-e0337622

2022

Volltextzugriff (PDF)

Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia

Blood, 2024-08, Vol.144 (8), p.809-821

2024

Volltextzugriff (PDF)

Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID‐19 serological assays as a proof of concept

Vox sanguinis, 2023-12, Vol.118 (12), p.1069-1077

2023

Volltextzugriff (PDF)

Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?

Frontiers in immunology, 2022-09, Vol.13, p.954093-954093

2022

Volltextzugriff (PDF)

Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population

Microbiology spectrum, 2022-02, Vol.10 (1), p.e0145421

2022

Volltextzugriff (PDF)

Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273

Microbiology spectrum, 2022-04, Vol.10 (2), p.e0270221-e0270221

2022

Volltextzugriff (PDF)

A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval

Clinical infectious diseases, 2022-08, Vol.75 (1), p.e888-e891

2022

Volltextzugriff (PDF)

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG

Journal of clinical virology, 2022-01, Vol.146, p.105050-105050, Article 105050

2022

Volltextzugriff (PDF)

1158. Immunogenicity of COVID-19 vaccine four-dose series in healthy community dwelling adults 50 years and above: interim analysis from the ‘PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines’ (PREVENT-COVID) study

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

1165. Longitudinal Evaluation of SARS-CoV-2 Antibody Response Using Dried Blood Spot Samples Following Vaccination with Three and Four Doses of mRNA-1273, BNT162b2 and/or ChAdOx1-S in Adults Aged 50 and Above: Interim Analysis from the PREVENT-COVID Study

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity

Curēus (Palo Alto, CA), 2023-01

2023

Volltextzugriff (PDF)

Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination

Access microbiology, 2023, Vol.5 (11)

2023

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(16)
Covid-19
(11)
Humans
(11)
Sars-Cov-2
(9)
Antibodies, Viral
(8)
Covid-19 Vaccines
(7)
Antibodies
(6)
Immunology
(6)
Severe Acute Respiratory Syndrome Coronavirus 2
(6)
Immunoglobulin G
(5)
Public Health
(5)
Vaccination
(5)
Covid-19 - Prevention & Control
(4)
Epstein-Barr Virus
(4)
Microbiology
(4)
Multidisciplinary Sciences
(4)
Multiple Sclerosis
(4)
Prospective Studies
(4)
Science & Technology - Other Topics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multiple Sclerosis-Like Symptoms in Mice Are Driven by Latent γHerpesvirus-68 Infected B Cells

Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis

Influence of Type I Interferons in Gammaherpesvirus-68 and Its Influence on EAE Enhancement

The Role of Latently Infected B Cells in CNS Autoimmunity

Adaptive immune responses to two-dose COVID-19 vaccine series in healthy Canadian adults ≥ 50 years: a prospective, observational cohort study

Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults

Spatial kinetics and immune control of murine cytomegalovirus infection in the salivary glands

Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada

Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex

Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study

Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response

Erratum for Nikiforuk et al., “Performance of Immunoglobulin G Serology on Finger Prick Capillary Dried Blood Spot Samples to Detect a SARS-CoV-2 Antibody Response”

Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia

Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID‐19 serological assays as a proof of concept

Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?

Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population

Comparative 6-Month Wild-Type and Delta-Variant Antibody Levels and Surrogate Neutralization for Adults Vaccinated with BNT162b2 versus mRNA-1273

A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval

A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG

1158. Immunogenicity of COVID-19 vaccine four-dose series in healthy community dwelling adults 50 years and above: interim analysis from the ‘PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines’ (PREVENT-COVID) study

1165. Longitudinal Evaluation of SARS-CoV-2 Antibody Response Using Dried Blood Spot Samples Following Vaccination with Three and Four Doses of mRNA-1273, BNT162b2 and/or ChAdOx1-S in Adults Aged 50 and Above: Interim Analysis from the PREVENT-COVID Study

Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity

Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination

Suchergebnisse filtern